Eleni Karapanagiotou
Papers
1
Total Citations
17
H-Index
1
About
Eleni Karapanagiotou is a leading thoracic surgical oncologist whose work focuses on the intersection of immunotherapy and advanced lung cancer surgery. Her key research areas include salvage pulmonary resection following immune checkpoint inhibitor therapy, the management of stage IIIb–IV non-small-cell lung cancer, and the evolving role of surgery in multimodality treatment paradigms. Her most cited work, a 2021 case series and literature review on salvage pulmonary resection after immunotherapy, has garnered 17 citations and provides critical early evidence that surgery can be safely and effectively performed in this challenging patient population. This contribution helps define new surgical indications in an era of rapidly advancing systemic therapies. Karapanagiotou’s research is particularly notable for addressing a previously unclear clinical scenario—whether thoracic surgery has a role after immune checkpoint inhibitor failure—and her findings have informed treatment guidelines and sparked further investigation into surgical timing and patient selection. Her work bridges the gap between medical oncology and thoracic surgery, offering hope for patients with advanced disease who have exhausted standard options.
Research Focus
Key Achievements
Top Papers
- 1